Avian pneumovirus vaccine

US6977079B2 · kind B2 · utility

Assignee

• Regents of the University of Minnesota · US

Inventors

• Kakambi Nagaraja · Windom, US
• Richard S. Bennett · North Potomac, US
• David Halvorson · Windom, US
• Moses Kariuki Njenga · Woodbury, US

Key dates

• Filing date: Jan 17, 2003
• Grant date: Dec 20, 2005
• Expiry date: Jan 17, 2023

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2760/18334
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compositions and methods for ameliorating the clinical signs of an avian pneumovirus (APV) infection in a bird are disclosed. The compositions include immunologically effective amounts of an avirulent APV isolated from Canada geese. Methods for preparing avirulent Canada goose APV compositions and vaccines are also described.